• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铂(II)O,S 配合物作为潜在的顺铂耐药性金属药物。

Platinum(ii) O,S complexes as potential metallodrugs against Cisplatin resistance.

机构信息

Institut für Anorganische und Analytische Chemie Friedrich-Schiller-Universität Jena Humboldtstraße 8, 07743 Jena, Germany.

Department of Gynecology, Jena University Hospital - Friedrich Schiller University Jena, Germany.

出版信息

Dalton Trans. 2016 Nov 29;45(47):18876-18891. doi: 10.1039/c6dt01388k.

DOI:10.1039/c6dt01388k
PMID:27897281
Abstract

We report on platinum(ii) complexes with different cinnamic acid derivatives as ligands with cytotoxic activity against Cisplatin resistant ovarian cancer cell line subcultures of SKOV3 and A2780. A typical mechanism of action for platinum(ii) complexes as Cisplatin itself is binding to the DNA and inducing double-strand breaks. We examined the biological behavior of these potential drugs with 9-methylguanine using NMR spectroscopic methods and their DNA damage potential including γH2AX-foci analyses. X-ray diffraction methods have been used to elucidate the molecular structures of the platinum(ii) complexes. Interactions with the model protein lysozyme have been evaluated by different techniques including UV-Vis absorption spectroscopy, fluorescence and X-ray crystallography.

摘要

我们报告了一系列以不同肉桂酸衍生物作为配体的铂(II)配合物,这些配合物对顺铂耐药的卵巢癌细胞系 SKOV3 和 A2780 的亚系具有细胞毒性。铂(II)配合物与顺铂本身一样,其典型的作用机制是与 DNA 结合并诱导双链断裂。我们使用 NMR 光谱方法研究了这些潜在药物与 9-甲基鸟嘌呤的相互作用,并通过 γH2AX 焦点分析研究了它们的 DNA 损伤潜力。X 射线衍射方法已被用于阐明铂(II)配合物的分子结构。通过包括紫外可见吸收光谱、荧光和 X 射线晶体学在内的不同技术,评估了它们与模型蛋白溶菌酶的相互作用。

相似文献

1
Platinum(ii) O,S complexes as potential metallodrugs against Cisplatin resistance.铂(II)O,S 配合物作为潜在的顺铂耐药性金属药物。
Dalton Trans. 2016 Nov 29;45(47):18876-18891. doi: 10.1039/c6dt01388k.
2
Synthesis, characterization and biological investigation of platinum(ii) complexes with asparagusic acid derivatives as ligands.以天门冬氨酸衍生物为配体的铂(II)配合物的合成、表征及生物学研究。
Dalton Trans. 2019 Jan 15;48(3):936-944. doi: 10.1039/c8dt02553c.
3
Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.1,3 - 二氨基丙烷和1,4 - 二氨基丁烷的铂(II)和铂(IV)配合物的制备与表征:克服顺铂耐药性及在CH1cisR卵巢肿瘤细胞中形成DNA链间交联
J Med Chem. 2002 Apr 25;45(9):1835-44. doi: 10.1021/jm010968l.
4
Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.新型基于四唑的铂(II)和钯(II)氯代配合物的合成、表征和生物学评价——顺铂类似物及其反式异构体的有效化合物。
J Inorg Biochem. 2013 Mar;120:44-53. doi: 10.1016/j.jinorgbio.2012.12.001. Epub 2012 Dec 13.
5
Toward overcoming cisplatin resistance via sterically hindered platinum(II) complexes.通过空间位阻铂(II)配合物克服顺铂耐药性。
Eur J Med Chem. 2016 May 23;114:141-52. doi: 10.1016/j.ejmech.2016.02.060. Epub 2016 Feb 27.
6
Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms.高细胞毒性锇(II)化合物及其靶向卵巢癌细胞系并规避顺铂耐药机制的钌(II)类似物。
Int J Mol Sci. 2022 Apr 29;23(9):4976. doi: 10.3390/ijms23094976.
7
Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.反式-双-(2-羟基吡啶)二氯合铂(II)的合成及其在人卵巢肿瘤模型中的活性。
Anticancer Res. 2012 Jan;32(1):135-40.
8
Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs.具有立体化学定义的硫杂环庚烷二氧化物二胺配体的铂(II)配合物作为抗癌药物。
Anticancer Res. 2006 May-Jun;26(3A):1815-9.
9
New platinum(IV) complex with adamantylamine ligand as a promising anti-cancer drug: comparison of in vitro cytotoxic potential towards A2780/cisR cisplatin-resistant cell line within homologous series of platinum(IV) complexes.新型含金刚烷胺配体的铂(IV)配合物作为一种有前景的抗癌药物:在铂(IV)配合物同系物中对A2780/cisR顺铂耐药细胞系的体外细胞毒性潜力比较
Anticancer Drugs. 2004 Jun;15(5):537-43. doi: 10.1097/01.cad.0000127147.57796.e5.
10
Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.大分子铂配合物在顺铂耐药肿瘤细胞中的细胞蓄积及细胞毒性
J Control Release. 2008 Oct 21;131(2):100-6. doi: 10.1016/j.jconrel.2008.07.017. Epub 2008 Jul 18.

引用本文的文献

1
Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with , Bidendate Cinnamic Acid Ester Derivatives: An In Vitro Cytotoxic Comparison to Ruthenium(II) and Osmium(II) Analogues.新型镍(II)、钯(II)和铂(II)配合物与, 双齿肉桂酸酯衍生物:与钌(II)和锇(II)类似物的体外细胞毒性比较。
Int J Mol Sci. 2022 Jun 15;23(12):6669. doi: 10.3390/ijms23126669.
2
Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms.高细胞毒性锇(II)化合物及其靶向卵巢癌细胞系并规避顺铂耐药机制的钌(II)类似物。
Int J Mol Sci. 2022 Apr 29;23(9):4976. doi: 10.3390/ijms23094976.
3
Platinum(II) , Complexes Inhibit the Aggregation of Amyloid Model Systems.
铂(II)配合物抑制淀粉样模型系统的聚集。
Int J Mol Sci. 2019 Feb 14;20(4):829. doi: 10.3390/ijms20040829.
4
Curcuminoid-BF complexes: Synthesis, fluorescence and optimization of BF group cleavage.姜黄素 - BF 配合物:BF 基团裂解的合成、荧光及优化
Beilstein J Org Chem. 2017 Oct 26;13:2264-2272. doi: 10.3762/bjoc.13.223. eCollection 2017.